RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

G Hrustanovic, V Olivas, E Pazarentzos, A Tulpule… - Nature medicine, 2015 - nature.com
One strategy for combating cancer-drug resistance is to deploy rational polytherapy up front
that suppresses the survival and emergence of resistant tumor cells. Here we demonstrate in …
被引用次数：298 相关文章

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer

G Hrustanovic, V Olivas, E Pazarentzos… - Nature …, 2015 - pubmed.ncbi.nlm.nih.gov
One strategy for combating cancer-drug resistance is to deploy rational polytherapy up front
that suppresses the survival and emergence of resistant tumor cells. Here we demonstrate in …

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer

G Hrustanovic, V Olivas, E Pazarentzos… - Nature …, 2015 - okayama.elsevierpure.com
抄録 One strategy for combating cancer-drug resistance is to deploy rational polytherapy up
front that suppresses the survival and emergence of resistant tumor cells. Here we …

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer

G Hrustanovic, V Olivas… - Nature …, 2015 - mdanderson.elsevierpure.com
One strategy for combating cancer-drug resistance is to deploy rational polytherapy up front
that suppresses the survival and emergence of resistant tumor cells. Here we demonstrate in …

[引用][C] RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

G Hrustanovic, V Olivas, E Pazarentzos, A Tulpule… - Nature Medicine, 2015 - cir.nii.ac.jp
[HTML] nih.gov

[HTML][HTML] RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

G Hrustanovic, V Olivas, E Pazarentzos… - Nature …, 2015 - ncbi.nlm.nih.gov
One strategy for combating cancer-drug resistance is to deploy rational polytherapy up front
that suppresses the survival and emergence of resistant tumor cells. Here we demonstrate in …

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.

G Hrustanovic, V Olivas, E Pazarentzos… - Nature …, 2015 - escholarship.org
One strategy for combating cancer-drug resistance is to deploy rational polytherapy up front
that suppresses the survival and emergence of resistant tumor cells. Here we demonstrate in …

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer

G Hrustanovic, V Olivas, E Pazarentzos, A Tulpule… - Nature Medicine, 2015 - go.gale.com
One strategy for combating cancer-drug resistance is to deploy rational polytherapy up front
that suppresses the survival and emergence of resistant tumor cells. Here we demonstrate in …

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.

G Hrustanovic, V Olivas, E Pazarentzos… - Nature …, 2015 - search.ebscohost.com
One strategy for combating cancer-drug resistance is to deploy rational polytherapy up front
that suppresses the survival and emergence of resistant tumor cells. Here we demonstrate in …

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.

G Hrustanovic, V Olivas, E Pazarentzos, A Tulpule… - Nature …, 2015 - europepmc.org
One strategy for combating cancer-drug resistance is to deploy rational polytherapy up front
that suppresses the survival and emergence of resistant tumor cells. Here we demonstrate in …